Founded in 2000, Nexstim Oy is a medical device company developing non-invasive, image-guided transcranial magnetic stimulation (TMS) for brain diagnostics and therapy. Cleared by the FDA (December 2009) for mapping the motor cortex in the brain prior to neurosurgery, the Nexstim Navigated Brain Stimulation (NBS) System is the first and only navigated TMS device commercially available in the USA.
Used by 50 hospitals world-wide, Nexstim NBS has multiple therapeutic applications, including stroke, in addition to applications in brain diagnostics. Finland-based Nexstim Oy's main investors are Sitra, HealthCap and LSP.

Web: www.nexstim.com/